Drugs / Follicle Stimulating Hormone
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 01 trial · 1 missed | ||||||
| Phase 0 | NCT03356964 | Nov 2017 → Feb 2020 | progesterone resistance | ART Fertility Clinics LLC | Completed | Missed primary |
| Phase 11 trial | ||||||
| Phase 1 | NCT06414096 | Oct 2024 → Nov 2025 overdue | female infertility, obesity disorder | University of Colorado, Denver | Recruiting | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00064987 | Apr 2001 → Oct 2012 | Kallmann syndrome | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Terminated | No outcome recorded Stop: Enrollment |
| Phase 41 trial | ||||||
| Phase 4 | NCT04430621 | Jul → Aug 2020 | — | Federico II University | Unknown | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 1/2 | NCT02179255 Background | Aug 2014 → Jun 2021 | female infertility | Center for Human Reproduction | Unknown | No outcome recorded |
| Phase 3 | NCT07346235 Comparator | Mar 2026 → Jan 2028 expected | female infertility | American Hospital 2 Kosovo | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT01044862 Comparator | Jun 2010 → Oct 2013 | infertility disorder, pregnancy disorder | Yale University | Completed | No outcome recorded |
| Phase 4 | NCT01403532 Comparator | Sep 2009 → Dec 2012 | Kallmann syndrome | Shanghai Jiao Tong University School of Medicine | Completed | Met primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | follicle stimulating hormone | “Follicle stimulating hormone(FSH),75U, im, 3 times/week, one year;” NCT01403532 ↗ |
| Known as | FSH | “Follicle stimulating hormone(FSH),75U, im, 3 times/week, one year;” NCT01403532 ↗3“Follicle Stimulating Hormone (FSH)” NCT01044862 ↗ “Follicle-stimulating hormone (FSH)” NCT07346235 ↗ “follicle stimulating hormone (FSH)” NCT00064987 ↗ |
| Modality | Protein / enzyme biologic | “recombinant follicle-stimulating hormone pretreatment” PMID 24037890 ↗ Sep 2013 |
| Route | Subcutaneous | “75 IU subcutaneous injection daily for four months.” NCT00064987 ↗ |